Semaglutide in Psychiatry—Opportunities and Challenges
Sri Mahavir Agarwal, Margaret Hahn
Abstract
This Viewpoint discusses clinical trial results of glucagon-like peptide 1 receptor agonists for treating the weight gain and cardiovascular disease risk of psychiatric medications.
Topics & Concepts
SemaglutideMedicinePsychiatryPsychologyPsychotherapistLiraglutideDiabetes mellitusType 2 diabetesEndocrinologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer